Most Recent
IP Australia shuts down another coffee capsule patent
For the third time this year, IP Australia has upheld a challenge to a coffee capsule patent, finding that the patent, owned by a unit of German food giant Kruger, was not inventive.
DLA Piper’s patent advice to Neurim not privileged, court hears
Two generic drug makers are fighting for access to confidential documents related to amendments by Neurim Pharmaceutical of patents covering its sleep drug Circadin, telling the Federal Court on Thursday privilege had been waived after a phone conversation between the company's founder and her lawyers from DLA Piper.